Posts by: Timea Polgar

Timea Polgar

Timea is a Molecular biologist (MSc) & Computational chemist (MSc, PhD), science liaison, and strategic business development and marketing specialist, with 15 years in pharmaceutical R&D, biotech and scientific software development.

June 23, 2016June 23, 2016

Kite Pharma Expands Development of Therapies Targeting HPV-Associated Cancers

News

Kite Pharma, a clinical-stage biopharma engaged in the development of novel cancer immunotherapy products, and the Experimental Transplantation and Immunology Branch (ETIB) of the National Cancer Institute signed a Cooperative ... Read more

April 7, 2016April 7, 2016

EF-IMRT Radiation Therapy Safe for Women with Cervical and Endometrial Cancer, Study Finds

News

Extended-field intensity modulated radiation therapy (EF-IMRT) can be safely used without risking duodenal toxicity in women with cervical or endometrial cancer in need of treatment to the para-aortic (PA) lymph nodes, researchers reported. The ... Read more